Semaglutides: Once A Week Weight Loss Injections
$16.99
593 in stock
Refresh Stock LevelInformation
Shipping
We currently offer free shipping on all orders over $100. Standard media mail shipping is $7.50 plus $1 for each additional book. Electronics are $35 shipping on all items.
Books
We get our books from a national distributor and although we strive to present up to date stock counts, stock constantly fluctuates. We perform a stock check when you add your book to the cart to ensure that it is available for shipping from the distributor. You can also check stock status by clicking the refresh stock link on the product page for the most up to date stock at the distributor. If an item is on backorder, you may place an order and we will update you on the estimated ship date as soon as we can confirm with the distributor.
Return & exchange
If you are not satisfied with your purchase you can return it to us within 14 days for an exchange or refund. More info.
Assistance
Can’t find what you’re looking for? We have access to over 13 million titles, reach out and see if we can help!
Contact us on (575) 322-6867, or email us at business@rabsbooks.com.
| Weight | 0.58 lbs |
|---|---|
| Dimensions | 9 × 6 × 0.4 in |
Description
Semaglutides: Ozempic, Wegovy and Mounjaro and Zepbound Produce Dramatic Weight Loss
Embark on a transformative journey towards lasting weight loss with “Semaglutides: Once a Week Weight Loss Injections.” In this groundbreaking guide, endocrinologist and weight loss expert, Dr Richard Lipman M.D. delves into the challenges of weight loss, the elusive nature of maintaining it, and the remarkable advantages offered by this revolutionary new group of medications-the Semaglutides and their newest partners, Tirzepatides.. Developed by experts around the world, this two group of medicatons have emerged as a game-changer in the realm of weight loss and diabetes treatment
Weight loss is an arduous undertaking that many individuals struggle with throughout their lives. Traditional approaches often yield temporary results, as the battle against stubborn pounds becomes an exhausting cycle of losing and regaining. But now, there is a glimmer of hope. Imagine shedding 3-4 pounds every week without succumbing to hunger pangs, uncontrollable cravings, or strenuous exercise. With semaglutides, this dream can become your reality.. These once-a-week injections work synergistically with your body, targeting the root causes of weight gain while suppressing appetite, reducing food cravings while producing profound fullness.
We guide you through every step of the process, from understanding the mechanism of action to creating a personalized injection regimen tailored to your specific needs. Say goodbye to crash diets and frustrating plateaus-this book empowers you with the tools to make lasting changes and reclaim control of your body.
Inside, you’ll find:
1. A comprehensive overview of Semaglutides and their impact on weight loss and especially weight maintenance.
2. Expert tips on how to maximize the effectiveness of Semaglutide injections including Ozempic, Wegovy and the Tirzepatides Mounjaro and Zepbound
3. Guidance on incorporating exercise and nutrition into your weight loss journey.
4. Strategies to overcome common obstacles such as slow weight loss and weight maintenance and stay motivated throughout your transformation.
5. Real-life success stories from Dr Lipman’s 800 ndividuals who have experienced remarkable results with Semaglutides over the past 2 years..
The advantages of semaglutides extend beyond mere weight loss. Through clinical trials, experts have observed positive effects on blood pressure, blood sugar levels, cholesterol, sleep apnea and overall cardiovascular health
Are you ready to take control of your weight and unlock a future of permanent weight loss and health? Let “Semaglutides: Once-a-Week Weight Loss Injections” be your guiding light on this life-changing —expedition. Grab your copy today and embark on a journey towards a healthier, happier you.
204 pages
Richard Lipman
Reviews
There are no reviews yet.